192 related articles for article (PubMed ID: 23803252)
41. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy.
Yokota T; Tachibana H; Konishi T; Yurikusa T; Hamauchi S; Sakai K; Nishikawa M; Suzuki M; Naganawa Y; Hagihara T; Tsumaki H; Kubo T; Sato M; Taguri M; Morita S; Eguchi T; Kubota K; Zenda S
Support Care Cancer; 2016 Jul; 24(7):3029-36. PubMed ID: 26887378
[TBL] [Abstract][Full Text] [Related]
42. gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: dependence on the dose-distribution, irradiated site and time from start of treatment.
Sak A; Grehl S; Erichsen P; Engelhard M; Grannass A; Levegrün S; Pöttgen C; Groneberg M; Stuschke M
Int J Radiat Biol; 2007 Oct; 83(10):639-52. PubMed ID: 17729159
[TBL] [Abstract][Full Text] [Related]
43. Assessment of Oral Mucositis among Patients Undergoing Radiotherapy for Head and Neck Cancer: An Audit.
Luitel A; Rimal J; Maharjan IK; Regmee P
Kathmandu Univ Med J (KUMJ); 2019 Jan.-Mar; 17(65):61-65. PubMed ID: 31734681
[TBL] [Abstract][Full Text] [Related]
44. Measurement of DNA damage in peripheral blood by the γ-H2AX assay as predictor of colorectal cancer risk.
Zhao L; Chang DW; Gong Y; Eng C; Wu X
DNA Repair (Amst); 2017 May; 53():24-30. PubMed ID: 28291710
[TBL] [Abstract][Full Text] [Related]
45. DNA double-strand breaks and their repair in blood lymphocytes of patients undergoing angiographic procedures.
Kuefner MA; Grudzenski S; Schwab SA; Wiederseiner M; Heckmann M; Bautz W; Lobrich M; Uder M
Invest Radiol; 2009 Aug; 44(8):440-6. PubMed ID: 19448553
[TBL] [Abstract][Full Text] [Related]
46. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus.
Morais-Faria K; Palmier NR; de Lima Correia J; de Castro Júnior G; Dias RB; da Graça Pinto H; Lopes MA; Ribeiro ACP; Brandão TB; Santos-Silva AR
Support Care Cancer; 2020 Sep; 28(9):4345-4352. PubMed ID: 31912359
[TBL] [Abstract][Full Text] [Related]
47. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
48. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
[TBL] [Abstract][Full Text] [Related]
49. Dimethyl Sulfoxide Prevents Radiation-Induced Oral Mucositis Through Facilitating DNA Double-Strand Break Repair in Epithelial Stem Cells.
Yang C; Tang H; Wang L; Peng R; Bai F; Shan Y; Yu Z; Zhou P; Cong Y
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1577-1589. PubMed ID: 30092334
[TBL] [Abstract][Full Text] [Related]
50. Evaluating Individual Radiosensitivity for the Prediction of Acute Toxicities of Chemoradiotherapy in Esophageal Cancer Patients.
Imano N; Nishibuchi I; Kawabata E; Kinugasa Y; Shi L; Sakai C; Ishida M; Sakane H; Akita T; Ishida T; Kimura T; Murakami Y; Tanaka K; Horikoshi Y; Sun J; Nagata Y; Tashiro S
Radiat Res; 2021 Mar; 195(3):244-252. PubMed ID: 33400798
[TBL] [Abstract][Full Text] [Related]
51. The response of gamma-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures.
Andrievski A; Wilkins RC
Int J Radiat Biol; 2009 Apr; 85(4):369-76. PubMed ID: 19399682
[TBL] [Abstract][Full Text] [Related]
52. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Hänscheid H; Gassen D; Biko J; Meineke V; Reiners C; Scherthan H
J Nucl Med; 2010 Aug; 51(8):1318-25. PubMed ID: 20660387
[TBL] [Abstract][Full Text] [Related]
53. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
Hong JP; Lee SW; Song SY; Ahn SD; Shin SS; Choi EK; Kim JH
Eur J Cancer Care (Engl); 2009 Nov; 18(6):636-41. PubMed ID: 19456848
[TBL] [Abstract][Full Text] [Related]
54. Establishment and multiparametric-cytogenetic validation of
Chaurasia RK; Bhat NN; Gaur N; Shirsath KB; Desai UN; Sapra BK
Mutat Res Genet Toxicol Environ Mutagen; 2021 Jun; 866():503354. PubMed ID: 33985694
[TBL] [Abstract][Full Text] [Related]
55. Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland.
Zwicker F; Swartman B; Sterzing F; Major G; Weber KJ; Huber PE; Thieke C; Debus J; Herfarth K
Radiat Oncol; 2011 Jun; 6():62. PubMed ID: 21649920
[TBL] [Abstract][Full Text] [Related]
56. Quantification of histone H2AX phosphorylation in white blood cells induced by ex vivo gamma irradiation of whole blood by both flow cytometry and foci counting as a dose estimation in rapid triage.
Wanotayan R; Wongsanit S; Boonsirichai K; Sukapirom K; Buppaungkul S; Charoenphun P; Songprakhon P; Jangpatarapongsa K; Uttayarat P
PLoS One; 2022; 17(3):e0265643. PubMed ID: 35320288
[TBL] [Abstract][Full Text] [Related]
57. Predicting Radiosensitivity with Gamma-H2AX Foci Assay after Single High-Dose-Rate and Pulsed Dose-Rate Ionizing Irradiation.
van Oorschot B; Hovingh S; Dekker A; Stalpers LJ; Franken NA
Radiat Res; 2016 Feb; 185(2):190-8. PubMed ID: 26789702
[TBL] [Abstract][Full Text] [Related]
58. The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.
Mlak R; Powrózek T; Brzozowska A; Homa-Mlak I; Mazurek M; Gołębiowski P; Sobieszek G; Małecka-Massalska T
Support Care Cancer; 2020 Feb; 28(2):531-540. PubMed ID: 31076897
[TBL] [Abstract][Full Text] [Related]
59. Symptoms Reported by Head and Neck Cancer Patients during Radiotherapy and Association with Mucosal Ulceration Site and Size: An Observational Study.
Gussgard AM; Jokstad A; Wood R; Hope AJ; Tenenbaum H
PLoS One; 2015; 10(6):e0129001. PubMed ID: 26060992
[TBL] [Abstract][Full Text] [Related]
60. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
